Full Text View
Tabular View
No Study Results Posted
Related Studies
SONICS - Effectiveness of Specialist Oncology Nursing
This study has been completed.
Study NCT00182234   Information provided by McMaster University
First Received: September 13, 2005   Last Updated: June 17, 2009   History of Changes

September 13, 2005
June 17, 2009
December 2005
March 2009   (final data collection date for primary outcome measure)
  • Difference in unmet supportive care needs between intervention and control group [ Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline ] [ Designated as safety issue: No ]
  • Difference in continuity of care between intervention and control group [ Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline ] [ Designated as safety issue: No ]
  • Difference in quality of life between intervention and control group [ Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline ] [ Designated as safety issue: No ]
  • Difference in unmet supportive care needs between intervention and control group
  • Difference in continuity of care between intervention and control group
  • Difference in quality of life between intervention and control group
  • Primary:
Complete list of historical versions of study NCT00182234 on ClinicalTrials.gov Archive Site
  • Difference in uncertainty in illness between intervention and control group [ Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline ] [ Designated as safety issue: No ]
  • Difference in use of resources between intervention and control group [ Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline ] [ Designated as safety issue: No ]
  • Acute stress following surgery [ Time Frame: 8 to 10 weeks after baseline ] [ Designated as safety issue: No ]
  • Secondary:
  • Difference in uncertainty in illness between intervention and control group
  • Difference in use of resources between intervention and control group
  • Acute stress following surgery
 
SONICS - Effectiveness of Specialist Oncology Nursing
A Study of the Effectiveness of Specialist Oncology Nursing Case Management in Improving Continuity of Supportive Cancer Care in the Community (SONICS)

This research project will address the issue of gaps in continuity of supportive care for cancer patients during the early phases of the disease trajectory that result in unmet needs and unnecessary morbidity. The investigators intend to study the impact of a specialized cancer-nursing program, Interlink Community Cancer Nurses (Interlink) on patient outcomes. Impact will be assessed directly using a validated measure of continuity of care from the patients' perspective and validated measures of key supportive care patient outcomes including unmet needs, distress, uncertainty in illness, and quality of life, in a randomized trial.

Main Research Question: Does community-based specialist oncology nursing case management improve continuity of cancer care and lead to fewer unmet cancer patient needs?

Why this research is important: This research proposal addresses the issue of gaps in continuity of supportive care for cancer patients during the early phases of the disease trajectory that result in unmet needs and unnecessary morbidity, prior to entry into a formalized cancer care system (e.g., a regional cancer centre or hospital with a cancer treatment program). This initial diagnostic period of cancer is associated with significant stress, anxiety and uncertainty that can impact upon overall quality of life for all types of cancer. These problems are further exacerbated by waiting times of up to 16 weeks between diagnosis and attendance in a formalized cancer treatment system. During this time patients will face a fragmented supportive care service system resulting in a substantial number of patients reporting unmet needs and distress. These care gaps have significant implications considering that 38% of women and 41% of men will develop cancer during their lifetime and that cancer incidence continues to rise with an estimated 139,000 new cases in Canada (over 54,000 of these in Ontario) in 2003. There has been growing interest in nursing models to address these gaps in supportive cancer care but at this time there is not sufficient high quality evidence upon which to base policy decisions to support the widespread introduction of this type of model. The results of this study will be very important for policy development for community cancer care in Ontario and in other provinces in Canada.

What is being studied: We will study the impact of a specialized nursing intervention (Interlink) on patient outcomes early in the disease trajectory. Impact will be assessed directly using validated measures in a randomized controlled trial design. These measures will include: continuity of care, unmet needs, psychological distress, uncertainty in illness, and quality of life.

Phase III
Interventional
Other, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
  • Continuity of Care
  • Quality of Life
Behavioral: Community Interlink Program
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
183
March 2009
March 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Histologically confirmed breast or colorectal cancer.
  • In the initial stages of surgical consultation within the randomized surgical practices.
  • Not had previous or concomitant malignancies (except for: non-melanoma skin cancer, or carcinoma in situ of the cervix).
  • Have been informed of cancer diagnosis by the surgical office.
  • Reside in the Interlink adult program service area.
  • Legally able to provide informed consent (18 years of age or older).
  • Able to speak and read English.
  • Patients from an intervention designated practice, must agree to referral to Interlink and to receiving an in-home needs assessment.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00182234
Dr. Jonathan Sussman, Hamilton Health Sciences
74867, CIHR - 74867, MOHLTC - 04171
McMaster University
  • Canadian Institutes of Health Research (CIHR)
  • Ontario Ministry of Health and Long Term Care
Principal Investigator: Jonathan Sussman, MD, CCFP, FRCP (c), MSc Supportive Cancer Care Research Unit
McMaster University
June 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP